Reference
Cho J-Y, et al. Analysis of the efficacy and safety of daclatasvir and asunaprevir in Korean genotype 1b chronic hepatitis C patients. Hepatology International 11 (Suppl. 1): S995 abstr. PP1694, Feb 2017. Available from: URL: http://doi.org/10.1007/s12072-016-9783-9 [abstract] - South Korea
Rights and permissions
About this article
Cite this article
Asunaprevir/daclatasvir. Reactions Weekly 1643, 47 (2017). https://doi.org/10.1007/s40278-017-27520-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-27520-9